Pfizer-BioNTech Covid-19 Vaccine - CDT Code Guide
Overview
CDT code D1713 refers to the administration of the Pfizer-BioNTech Covid-19 vaccine's first dose for pediatric patients. This code is part of the preventive category, emphasizing its role in disease prevention. The vaccine is administered intramuscularly, with a dosage of 10mcg/0.2mL using a tris-sucrose formulation. Dental professionals may encounter this code when coordinating care for pediatric patients who are receiving their initial Covid-19 vaccination as part of a comprehensive health strategy. Understanding this code is crucial for ensuring accurate billing and documentation in practices that offer or coordinate vaccination services.
When to Use This Code
- Administering the first dose of the Pfizer-BioNTech Covid-19 vaccine to pediatric patients
- Coordinating care for pediatric patients receiving Covid-19 vaccinations
- Billing for Covid-19 vaccination services in dental settings
- Documenting preventive care measures for pediatric patients
- Integrating comprehensive health services in dental practice
Documentation Requirements
- Patient's full name and date of birth
- Date of vaccine administration
- Vaccine manufacturer and lot number
- Dosage and route of administration
- Consent form signed by parent or guardian
- Documentation of any adverse reactions or follow-up care
Billing Considerations
Ensure the correct use of code D1713 for the first dose only. Verify patient eligibility and coverage with their insurance provider, as Covid-19 vaccines are often covered without patient cost-sharing. Be aware of any frequency limitations and use appropriate modifiers if required by the insurance plan.
Related CDT Codes
Frequently Asked Questions
No, D1713 is specifically for pediatric patients receiving the Pfizer-BioNTech Covid-19 vaccine.
Need help with dental coding?
Our AI-powered assistant can answer your CDT code questions instantly.